Common adverse effects include nausea and vomiting, as well as increased hazards of gastroparesis and small bowel obstruction
Accordingly, we encourage the adoption of GLP-1RA plus SGLT2i combination therapy in patients with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or multiple risk factors for ASCVD (i.e., age 55 years, overweight/obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria)
Amgens statement added that the long half-life, combined with its dual mechanism of action, means the drug may allow for greater durability or reduce the likelihood of weight regain after treatment stops
Use features like bookmarks, note taking and highlighting while reading THE ULTIMATE GLP-1 DIET MEAL PLAN COOKBOOK FOR BEGINNERS: Discover What to Eat to Regulate Blood Sugar, Suppress Appetite, and Support Your Weight Loss
Most side effects including digestive symptoms are mild to moderate, often improving after a few days or weeks
Lastly, we included a heterogeneous breast cancer cohort and did not evaluate cancer outcomes, as the primary objective was to assess weight change